Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03457168

Treatment of Hypertension During Sleep

Led by University of Vigo · Updated on 2024-12-06

5320

Participants Needed

9

Research Sites

726 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

On the basis of new evidence on the relationship between achieved office blood pressure (BP) measurements (OBPM) and the risk of cardiovascular disease (CVD) morbidity and mortality documented in the SPRINT trial, the recent 2017 guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA) have established lower values of 130/80 mmHg for clinic systolic BP (SBP)/diastolic BP (DBP) as new diagnostic thresholds for hypertension and therapeutic targets for treatment of all individuals aged ≥18 years regardless of age, sex, or concomitant complications including presence of diabetes, chronic kidney disease (CKD), or history of past CVD event. According to these guidelines, the new proposed ambulatory BP measurment (ABPM) thresholds for diagnosis of hypertension in adults are 130/80 and 110/65 mmHg for the awake and asleep SBP/DBP means, respectively. However, the ACC/AHA guidelines do not provide any scientific evidence documenting neither the equivalence between these ABPM thresholds and the 130/80 mmHg cut-off values for OBPM nor the potential improved CVD event-free survival time of the proposed more intensive control of ambulatory BP. Results derived from observational prospective studies consistently document that therapeutic BP targets in hypertensive individuals, i.e., persons at increased CVD risk, should be established in terms of proper control of asleep BP. To date, no prospective randomized study has ever before evaluated which should be the adequate therapeutic ABPM target for most effective reduction of CVD risk. Accordingly, the Tratamiento de Hipertensión Arterial Durante el Sueño study (THADEUS, i.e., Treatment of Hypertension During Sleep) has been designed to prospectively evaluate if "intensive control" of asleep SBP mean proposed by the new ACC/AHA guidelines (\<110 mmHg) in more effective than the so far its "conventional control" (\<120 mmHg) to reduce CVD morbidity and mortality in hypertensive individuals.

CONDITIONS

Official Title

Treatment of Hypertension During Sleep

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women aged �3E�3D18 years
  • Sleep-time hypertension with asleep SBP mean �3E�3D120 mmHg at randomization
  • Routine daytime activity and nighttime sleep
  • Provided written informed consent to participate
Not Eligible

You will not qualify if you...

  • Pregnancy
  • History of drug or alcohol abuse within the last two years
  • Night or shift work employment
  • Previous systemic autoimmune disease or AIDS
  • Secondary hypertension causes such as coarctation of the aorta, hyperaldosteronism, renal artery stenosis, or pheochromocytoma
  • Cardiovascular disorders including unstable angina, heart failure, life-threatening arrhythmia, atrial fibrillation, kidney failure, and severe retinopathy
  • Any surgical or medical condition affecting drug metabolism or increasing study risk or likelihood of non-compliance
  • History of malignancy or other severe life-threatening diseases within the past five years
  • Inability to communicate or comply with study requirements
  • Intolerance to ambulatory blood pressure monitoring

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Complexo Hospitalario Universitario de Ourense

Ourense, Orense, Spain, 32005

Actively Recruiting

2

CS A Estrada

A Estrada, Pontevedra, Spain, 26680

Actively Recruiting

3

CS Panxón

Nigrán, Pontevedra, Spain, 36340

Actively Recruiting

4

Centro de Salud de A Doblada

Vigo, Pontevedra, Spain, 36205

Actively Recruiting

5

Centro de Salud de Bembrive

Vigo, Pontevedra, Spain, 36214

Actively Recruiting

6

Centro de Salud de Sardoma

Vigo, Pontevedra, Spain, 36214

Actively Recruiting

7

CS Teis

Vigo, Pontevedra, Spain, 36216

Actively Recruiting

8

Bioengineering & Chronobilogy Labs., University of Vigo

Vigo, Pontevedra, Spain, 36310

Actively Recruiting

9

CS San Roque

Vilagarcía de Arousa, Pontevedra, Spain, 36600

Actively Recruiting

Loading map...

Research Team

R

Ramon C Hermida, PhD

CONTACT

J

José R Fernández, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Treatment of Hypertension During Sleep | DecenTrialz